We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

BioPerfectus Technologies

Bioperfectus Technologies Co., Ltd. is one of the leading molecular diagnostic solution providers in the global in-vi... read more Featured Products: More products

Download Mobile App




Bioperfectus Demonstrates Nucleic Acid Extraction Solutions at AACC 2021

By LabMedica International staff writers
Posted on 29 Sep 2021
Print article
Image: Bioperfectus Demonstrates Nucleic Acid Extraction Solutions at AACC 2021 (Photo courtesy of Jiangsu Bioperfectus Technologies Co., Ltd.)
Image: Bioperfectus Demonstrates Nucleic Acid Extraction Solutions at AACC 2021 (Photo courtesy of Jiangsu Bioperfectus Technologies Co., Ltd.)

Jiangsu Bioperfectus Technologies Co., Ltd. (Shanghai, China) demonstrated its range of nucleic acid extraction solutions at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo.

The event brought together 20,000 of the sharpest minds in clinical laboratory medicine for four science packed days. At the conference, attendees heard from the foremost experts on topics from personalized medicine and infectious diseases to point-of-care and laboratory-developed tests. At the Clinical Lab Expo, attendees evaluated hundreds of new technologies just coming to market that can enhance their lab.

At AACC 2021, Bioperfectus showcased its new SMPE-960 nucleic acid extraction system which is an in vitro diagnostic medical device that integrates cutting-edge mechanical, electronic and software technologies to enable automated extraction of nucleic acids from samples with a modular structure - the equipment can extract nucleic acids from 1-96 samples in three independently operating modules at the same time. Each module consists of 1-32 samples so that samples can be tested upon delivery.

Bioperfectus also displayed its Nucleic Acid Extraction Rapid Kit (Magnetic Bead Method) which uses magnetic beads and a buffer system with unique separation function. The kit is used in conjunction with the SMPE-960 nucleic acid extraction system to separate and purify high-quality viral nucleic acids from samples. The specially coated magnetic beads have a strong affinity for the nucleic acid in the sample under certain conditions. When the conditions change, the magnetic beads release the adsorbed nucleic acid, so that the nucleic acid in the purified sample can be quickly extracted. This kit is used for the extraction and purification of viral nucleic acids (DNA and RNA) from samples such as serum, plasma, virus culture fluid, cerebrospinal fluid, urine, swab wash, fecal supernatant, etc. The purified nucleic acid can be used in downstream molecular biology experiment.

Also on display at the event was the COVID-19 Coronavirus (ORF1ab/N/E) Real Time PCR Kit from Bioperfectus that is an In Vitro Diagnostic (IVD) reagent relying on fluorescent PCR technology and aiming at qualitatively detection and differentiation of human RNA from SARS-CoV-2 from upper and lower respiratory tract samples. Primer and probe are selected from Open Reading Frame gene region (ORF1a/b), envelope protein (E) and nucleocapsid region (N) for SARS-CoV-2. The kit is a multiplex assay, run in a single well/vessel, designed for detection and differentiation of RNA from SARS-CoV-2. In addition, the kit also contains human house-keeping gene (RNase P) for clinical sample detection. The product is intended for use on populations suspected to have SARS-CoV-2 infection, as an aid in the diagnosis of SARS-CoV-2 infection by trained laboratory personnel on RT-PCR.

In addition, Bioperfectus highlighted its Viral Nucleic Acid Extraction Kit (Magnetic Bead Method) which uses magnetic beads and a buffer system with unique separation function. The kit is used in conjunction with the SMPE-960 nucleic acid extraction system to separate and purify high-quality viral nucleic acids from samples. The specially coated magnetic beads have a strong affinity for the nucleic acid in the sample under certain conditions. When the conditions change, the magnetic beads release the adsorbed nucleic acid, so that the nucleic acid in the purified sample can be quickly extracted. This kit is used for the extraction and purification of viral nucleic acids (DNA and RNA) from samples such as serum, plasma, virus culture fluid, cerebrospinal fluid, urine, swab wash, fecal supernatant, etc. The purified nucleic acid can be used in a downstream molecular biology experiment.

Related Links:
Jiangsu Bioperfectus Technologies Co., Ltd. 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The real-time multiplex PCR test is set to revolutionize early sepsis detection (Photo courtesy of Shutterstock)

1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens

Sepsis contributes to one in every three hospital deaths in the US, and globally, septic shock carries a mortality rate of 30-40%. Diagnosing sepsis early is challenging due to its non-specific symptoms... Read more

Pathology

view channel
Image: The QIAseq xHYB Mycobacterium tuberculosis Panel uses next-generation sequencing (Photo courtesy of 123RF)

New Mycobacterium Tuberculosis Panel to Support Real-Time Surveillance and Combat Antimicrobial Resistance

Tuberculosis (TB), the leading cause of death from an infectious disease globally, is a contagious bacterial infection that primarily spreads through the coughing of patients with active pulmonary TB.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.